041960 — KOMIPHARM INTERNATIONAL CO Cashflow Statement
0.000.00%
- KR₩448bn
- KR₩471bn
- KR₩59bn
Annual cashflow statement for KOMIPHARM INTERNATIONAL CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3,957 | -5,934 | -7,480 | -5,911 | 14,690 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1,762 | 1,979 | 4,879 | 405 | -7,259 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,520 | -883 | -3,034 | -673 | -1,684 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 25.2 | -1,256 | -1,808 | -2,800 | 8,847 |
| Capital Expenditures | -1,685 | -1,184 | -1,065 | -1,129 | -3,978 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 119 | 439 | -310 | -2,373 | 5,957 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,566 | -745 | -1,376 | -3,502 | 1,979 |
| Financing Cash Flow Items | -647 | -1.11 | — | -37.9 | -6,362 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,640 | -1,022 | 2,034 | 10,531 | -13,231 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3,830 | -3,057 | -1,187 | 4,015 | -2,372 |